Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Dec 18, 2024
Open Peer Review Period: Dec 18, 2024 - Feb 12, 2025
Date Accepted: Apr 7, 2025
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The Impact of Technology-Enabled Virtual Medical Nutrition Therapy on Weight Loss in Adults with Overweight and Obesity: A Real-world, Observational Study
ABSTRACT
Background:
Obesity represents a major public health crisis in the United States, imposing substantial health risks and economic costs. Medical nutrition therapy (MNT) has been demonstrated to be an effective intervention for weight loss among patients with obesity. With the rise of telehealth, virtual MNT has gained popularity as an accessible alternative to traditional in-person care. A nationwide program was developed that integrates virtual MNT with a companion mobile app, offering a comprehensive approach to weight management. However, the effectiveness of this combined intervention has not yet been evaluated.
Objective:
To evaluate the effect of a virtual MNT program with a companion mobile app on weight loss in adults with overweight and obesity.
Methods:
This retrospective cohort study included users of Nourish, a virtual MNT program with a companion mobile app, who attended at least one appointment between August 2023 and October 2024 and had a baseline body mass index (BMI) 30 kg/m2 or a BMI between 27-30 kg/m2 with diabetes or prediabetes. Engagement was assessed based on completed appointments and app usage. Mean weight change, mean percent weight change, and proportion of participants who achieved at least 3% and 5% weight loss were calculated. T-tests were used to evaluate the statistical significance of weight change. Subgroup analyses were performed by follow-up time between weights, number of appointments completed, and level of engagement by appointments and app usage.
Results:
In total, 3,951 participants were included in the analysis. The mean (standard deviation (SD)) age was 38 (10) years, and 78% of participants were female. Weight loss was reported as a program goal by 70% of participants, with 31% self-reporting diabetes or prediabetes and 24% self-reporting a cardiovascular condition. Over a median follow-up of 2.2 months, 74% of participants experienced weight loss, and 34% and 17% achieved at least 3% and 5% weight loss, respectively. The mean (SD) weight change was -4.5 (8.9) pounds, corresponding to -2.0% (3.9) weight change (P<.001). Males and participants aged 60 years or older experienced greater weight loss than females and younger participants. Longer follow-up time between weights and a higher number of completed appointments (≥5 appointments) were significantly associated with a higher likelihood of achieving at least 5% weight loss (P<.001 for both). Additionally, participants who had the highest number of appointments and highest app engagement were more likely to achieve at least 5% weight loss compared to those with fewer appointments or lower app engagement (P<.001).
Conclusions:
Enrollment in a virtual MNT program with a companion mobile app was associated with clinically meaningful weight loss among adults with overweight and obesity across the United States, highlighting the potential of tech-enabled solutions to provide scalable weight management strategies.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.